What is Bonesupport?
BoneSupport AB is a Swedish medical device firm dedicated to pioneering orthobiologic solutions for bone healing and reconstruction. The company specializes in developing injectable synthetic bone graft substitutes designed to treat complex bone injuries, defects, and infections within orthopedic and trauma surgery. BoneSupport's proprietary technology leverages calcium sulfate and hydroxyapatite formulations, offering structural support and promoting natural bone regeneration while gradually resorbing. A key innovation is the ability to combine bone void filling with local antibiotic delivery, providing a dual-action approach for treating bone infections and supporting bone repair. The company actively collaborates with orthopedic surgeons and healthcare institutions globally, emphasizing clinical evidence and scientific research to advance care standards in musculoskeletal conditions.
How much funding has Bonesupport raised?
Bonesupport has raised a total of $256M across 5 funding rounds:
Unspecified
$15M
Unspecified
$120M
Unspecified
$70M
Private Equity
$14M
Private Equity
$37M
Unspecified (2006): $15M with participation from Innovations Kapital, Ferd Venture, and Teknoinvest
Unspecified (2011): $120M led by Industrifonden and HealthCap Partners
Unspecified (2012): $70M supported by HealthCap Partners, Industrifonden, and Lundbeckfond Ventures
Private Equity (2015): $14M, investors not publicly disclosed
Private Equity (2016): $37M backed by Kreos Capital, Industrifonden, HealthCap Partners, AP3, and Lundbeckfond Ventures
Key Investors in Bonesupport
Kreos Capital
Kreos Capital is a finance company specializing in investment services and business management, founded in 1998 and headquartered in London, UK. They provide growth capital to technology companies.
Industrifonden
Industrifonden is a Swedish venture capital fund that invests in scalable innovations, particularly in deep tech, life sciences, and transformative technologies, aiming to improve society.
HealthCap Partners
HealthCap Partners is a private equity firm focused on providing growth capital and real estate solutions for the healthcare industry, with a history of significant investments since 1996.
What's next for Bonesupport?
With a substantial enterprise-level funding history, Bonesupport appears to be in a mature growth phase, likely focusing on scaling its commercial operations and expanding its international market reach. The recent strategic investment suggests a strong confidence from backers in the company's technology and market potential. Future endeavors will likely involve further clinical validation, potential product line extensions, and strategic partnerships to broaden access to its orthobiologic solutions for patients worldwide. The company's focus on addressing challenging bone conditions positions it for continued impact in the orthopedic and trauma surgery markets.
See full Bonesupport company page
